This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

AVANIR Pharmaceuticals (AVNR)

NASDAQ: Health Care

Company Balance Sheet
Sep 2013 Sep 2012 Sep 2011 Sep 2010
Cash and Equivalents 55.26M 69.78M 79.54M 38.77M
Receivables 12.53M 7.23M 2.01M 580.91K
Inventories 710.18K 415.48K 252.24K 652.63K
Other Current Assets 2.38M 865.34K 520.49K 52.87K
Total Current Assets 71.84M 80.91M 84.39M 40.69M
Property, Plant & Equipment, Gross 4.99M 4.38M 3.57M 2.45M
Accumulated Depreciation & Depletion 3.40M 2.58M 1.88M 2.00M
Property, Plant & Equipment, Net 1.59M 1.81M 1.70M 449.71K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 2.64M 3.29M 3.56M 1.00M
Total Non-Current Assets 4.24M 5.10M 5.26M 1.45M
Liabilities & Shareholder Equity
Total Assets 76.08M 86.01M 89.65M 42.14M
Accounts Payable 5.88M 2.93M 3.26M 2.11M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 344.86K 0.00 0.00 0.00
Total Current Liabilities 34.79M 20.32M 14.19M 7.72M
Long Term Debt 21.42M 26.70M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.39M 2.16M 4.12M 6.41M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 22.82M 28.86M 4.12M 6.41M
Total Liabilities 57.61M 49.17M 18.31M 14.13M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 18.47M 36.84M 71.34M 28.01M
Common Par 15.21K 13.64K 12.54K 9.60K
Additional Paid In Capital 518.99M 461.88M 436.64M 332.10M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -500.54M -425.06M -365.32M -304.68M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 580.91K
Total Capitalization 39.89M 63.54M 71.34M 28.01M
Total Equity 18.47M 36.84M 71.34M 28.01M
Total Liabilities & Stock Equity 76.08M 86.01M 89.65M 42.14M
Total Common Shares Outstanding 152.06M 136.44M 125.44M 95.97M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 142.27M 133.36M 119.41M 87.61M
Diluted Weighted Shares Outstanding 142.27M 133.36M 119.41M 87.61M
Number of Employees 267 225 188 128
Number of Part-Time Employees 0 0 0 0

AVNR AVANIR Pharmaceuticals

Analysts Ratings for AVNR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

AVNR Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs